These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6098109)

  • 21. [A live vaccine against tick-borne encephalitis: the principles of selecting the vaccinal strains].
    Kamalov II; Sokolova ED; Il'enko VI; Rozhkova LV
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):70-6. PubMed ID: 8067096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-mediated immunity in flavivirus infections. I. Induction of cytotoxic T lymphocytes in mice by an attenuated virus from the tick-borne encephalitis complex and its group-reactive character.
    Gajdosová E; Oravec C; Mayer V
    Acta Virol; 1981 Jan; 25(1):10-8. PubMed ID: 6165230
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
    Tsouchnikas G; Zlatkovic J; Jarmer J; Strauß J; Vratskikh O; Kundi M; Stiasny K; Heinz FX
    J Virol; 2015 Aug; 89(15):7970-8. PubMed ID: 26018152
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reactive killer T lymphocytes in a flavivirus infection.
    Gajdosová E; Mayer V; Oravec C
    Acta Virol; 1980 Jun; 24(4):291-3. PubMed ID: 6106380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnitude and Functional Profile of the Human CD4
    Varnaitė R; Blom K; Lampen MH; Vene S; Thunberg S; Lindquist L; Ljunggren HG; Rombo L; Askling HH; Gredmark-Russ S
    J Immunol; 2020 Feb; 204(4):914-922. PubMed ID: 31924650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [2 aspects of immunity in experimental flavivirus infections].
    Semenov BF; Khozinskiĭ VV
    Vopr Virusol; 1978; (3):317-21. PubMed ID: 211731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human CD4+ T Helper Cell Responses after Tick-Borne Encephalitis Vaccination and Infection.
    Aberle JH; Schwaiger J; Aberle SW; Stiasny K; Scheinost O; Kundi M; Chmelik V; Heinz FX
    PLoS One; 2015; 10(10):e0140545. PubMed ID: 26465323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
    Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
    Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum factor blocking the activity of virus-induced autoreactive T lymphocytes of mice.
    Khozinsky VV; Semenov BF
    Acta Virol; 1983 Jul; 27(4):346-50. PubMed ID: 6138997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human antibody response to immunization with 17D yellow fever and inactivated TBE vaccine.
    Kayser M; Klein H; Paasch I; Pilaski J; Blenk H; Heeg K
    J Med Virol; 1985 Sep; 17(1):35-45. PubMed ID: 2995571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
    Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
    BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of the Tahyña virus on Langat virus persistence in the central nervous system of the mouse].
    Semenov BF; Vargin VV; Ozherelkov SV
    Vopr Virusol; 1981; (6):724-8. PubMed ID: 6278778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of inbred mice for assessing the neurovirulence of strains of the tick-borne encephalitis virus complex and the immunogenicity of a concentrated tick-borne encephalitis vaccine].
    Kan GA; Borsuk EA; Vorob'eva MS
    Vopr Virusol; 1982; 27(4):461-4. PubMed ID: 7135927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
    Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against European isolates of tick-borne encephalitis virus after vaccination with a new tick-borne encephalitis vaccine.
    Klockmann U; Krivanec K; Stephenson JR; Hilfenhaus J
    Vaccine; 1991 Mar; 9(3):210-2. PubMed ID: 2042394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines.
    Ruzek D; Avšič Županc T; Borde J; Chrdle A; Eyer L; Karganova G; Kholodilov I; Knap N; Kozlovskaya L; Matveev A; Miller AD; Osolodkin DI; Överby AK; Tikunova N; Tkachev S; Zajkowska J
    Antiviral Res; 2019 Apr; 164():23-51. PubMed ID: 30710567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of tick-borne encephalitis DNA vaccines in monkeys.
    Schmaljohn C; Custer D; VanderZanden L; Spik K; Rossi C; Bray M
    Virology; 1999 Oct; 263(1):166-74. PubMed ID: 10544091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Characteristics of the response of mice with temporary immunodepression to the administration of live or inactivated vaccine against tick-borne encephalitis].
    Vargin VV; Semenov BF
    Vopr Virusol; 1979; (1):52-7. PubMed ID: 217179
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein.
    Aleshin SE; Timofeev AV; Khoretonenko MV; Zakharova LG; Pashvykina GV; Stephenson JR; Shneider AM; Altstein AD
    BMC Microbiol; 2005 Aug; 5():45. PubMed ID: 16076390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change in host immune response to heterologous antigen when exposed to togavirus infection].
    Vargin VV; Semenov BF
    Vopr Virusol; 1976; (2):150-4. PubMed ID: 936570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.